Tower Research Capital LLC (TRC) - CORMEDIX INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CORMEDIX INC
ValueSharesWeighting
Q3 2023$12,158
-75.4%
3,286
-73.6%
0.00%
-100.0%
Q2 2023$49,380
+164500.0%
12,454
+70.3%
0.00%
+100.0%
Q1 2023$30
-3.2%
7,314
-0.1%
0.00%0.0%
Q4 2022$31
-100.0%
7,324
-84.0%
0.00%
-50.0%
Q3 2022$129,000
+514.3%
45,696
+1067.5%
0.00%
Q1 2022$21,000
+50.0%
3,914
+30.7%
0.00%
Q4 2021$14,000
+55.6%
2,995
+47.4%
0.00%
Q3 2021$9,000
-70.0%
2,032
-53.4%
0.00%
-100.0%
Q2 2021$30,000
+36.4%
4,365
+98.5%
0.00%
Q1 2021$22,000
-60.0%
2,199
-70.5%
0.00%
-100.0%
Q4 2020$55,000
-71.1%
7,443
-76.4%
0.00%0.0%
Q3 2020$190,000
+341.9%
31,505
+363.2%
0.00%0.0%
Q2 2020$43,000
+290.9%
6,802
+120.9%
0.00%
+100.0%
Q1 2020$11,000
-50.0%
3,079
+3.7%
0.00%
-50.0%
Q4 2019$22,000
-24.1%
2,968
-34.7%
0.00%0.0%
Q3 2019$29,0004,5450.00%
Other shareholders
CORMEDIX INC shareholders Q4 2023
NameSharesValueWeighting ↓
Spinnaker Capital LLC 175,384$1,752,0002.16%
PLANNING DIRECTIONS INC 50,000$500,0000.39%
HGI Capital Management, LLC 33,207$332,0000.14%
Elliott Investment Management L.P. 1,550,523$15,490,0000.12%
OXFORD FINANCIAL GROUP, LTD. LLC 60,905$608,0000.08%
RIVERSEDGE ADVISORS, LLC 14,259$142,0000.06%
Cresset Asset Management, LLC 329,796$3,295,0000.05%
Maven Securities LTD 111,065$1,076,0000.05%
Wealthstreet Investment Advisors, LLC 31,200$312,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 153,100$1,529,0000.03%
View complete list of CORMEDIX INC shareholders